2025-08-29 22:10:56
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Metropolis Healthcare Ltd consolidated net profit declines to Rs. 39.98 crores in Q4FY22
Posted On : 2022-05-25 00:27:12( TIMEZONE : IST )
Metropolis Healthcare Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 311.5762 crores during the period ended March 31, 2022 as compared to Rs. 295.6628 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 39.9866 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 41.0388 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 7.78 for the period ended March 31, 2022 as compared to Rs. 7.98 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 311.5762 crs | ₹295.6628 crs |  5.38% |
| Net Profit | ₹39.9866 crs | ₹41.0388 crs |  -2.56% |
| EPS | ₹7.78 | ₹7.98 | -2.51% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 311.5762 crores during the period ended March 31, 2022 as compared to Rs.293.7962 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.39.9866 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.61.3464 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.7.78 for the period ended March 31, 2022 as compared to Rs.11.99 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 311.5762 crs | ₹293.7962 crs | 6.05% |
| Net Profit | ₹39.9866 crs | ₹61.3464 crs | -34.82% |
| EPS | ₹7.78 | ₹11.99 | -35.11% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1245.9590 crores during the Financial Year ended March 31, 2022 as compared to Rs.1010.0322 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.214.1820 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.183.9051 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.41.66 for the Financial Year ended March 31, 2022 as compared to Rs.35.79 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹1245.9590 crs | ₹1010.0322 crs | 23.36% |
| Net Profit | ₹214.1820 crs | ₹183.9051 crs | 16.46% |
| EPS | ₹41.66 | ₹35.79 | 16.40% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 1688.50 as compared to the previous close of Rs. 1755.20. The total number of shares traded during the day was 4345 in over 876 trades.
The stock hit an intraday high of Rs. 1773.00 and intraday low of 1652.35. The net turnover during the day was Rs. 7460745.00.
